Thursday, May 7, 2026

ProGen’s PG-110 Targets Fat Loss Without Muscle Waste—Next-Gen Obesity Drug in Focus

ProGen will present non-clinical results of its obesity drug PG-110 at the ADA conference, targeting muscle preservation and weight loss.

Coupang Ranked Second Most Innovative Retail Company by Fast Company

Coupang ranks second in Fast Company's 2025 most innovative retail companies, praised for growth, tech investments, and logistics.

Korea vs. U.S.: Will Trade Law 301 Affect Korean Manufacturing in 2026?

South Korea defends its manufacturing practices against U.S. investigations into overproduction and forced labor, asserting market principles.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.

Smoker? Heavy Drinker? You’re at Risk for This Silent Cancer

Tongue cancer is rare yet rising among younger adults. Early detection and treatment are crucial for survival and preserving function.

Bladder Cancer: The Silent Risk You Shouldn’t Ignore After 40

May is Bladder Cancer Awareness Month; smoking increases risk. Regular screenings are vital for early detection and improved survival rates.

Cancer Gone for 3 Years? This New Drug Is Making It Happen

AbbVie's Epkinly shows 96% long-term complete remission in R/R large B-cell lymphoma patients, highlighting its effectiveness as a therapy.

Sleep Apnea Cases Triple in 5 Years—Here’s What to Watch For

Sleep apnea cases in South Korea surged 3.4 times in five years, especially among middle-aged individuals, stressing early diagnosis and treatment.

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Breakthrough Tech Tailors Gene Editing to Your DNA

Researchers at Pusan National University developed a tool for personalized gene editing, predicting side effects based on DNA variations.

Dark Skin Patches in Teens? It Could Be a Warning Sign, Doctors Say

Dark patches on skin folds in adolescents may indicate Acanthosis Nigricans, linked to obesity and insulin resistance. Consult a specialist.

Why Your Legs Feel Like Lead at Night—And What to Do About It

Varicose veins are common due to prolonged standing or sitting. Early treatment is vital to prevent complications and manage symptoms.

Cigarettes vs. DNA: Study Shows Smoking Is the Real Cancer Trigger

A study shows that smoking for over 20 years increases small-cell lung cancer risk by 54 times, highlighting smoking's dangers.

J&J Aims to Treat Cancer Before It Starts Showing Symptoms

Johnson & Johnson leads in multiple myeloma treatment, pioneering early intervention for high-risk patients with a new subcutaneous formulation.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

Hidden Risk in Aging Parents: A Minor Fall Could Mean a Major Fracture

Mother's Day highlights the importance of checking parents' bone health, as many older adults unknowingly suffer from osteoporosis.

Hypertension Hits Young Adults Hard — But They’re Not Getting Treated

Nearly 10 million die from hypertension yearly. Awareness is low among young adults, increasing health risks and complications.

Top News

- Our Sponsors Ad -

Follow us